title: Iatrogenic calcinosis cutis following nadroparin injection.
abstract: Accumulation of calcium in the skin is usually classified as a group of disorders referred to as calcinosis cutis. We report the case of a patient who developed iatrogenic calcinosis at the site of subcutaneous administration of low-molecular-weight heparins (LMWH) as nadroparin. This is usually used for the prevention of deep venous thrombosis, especially following renal transplantation. The role of calcium content in nadroparin is discussed.
authors.affiliation: Department of Dermatological Sciences, University of Florence, Florence, Italy. Simygiorgini@libero.it
authors.forename: Simonetta
authors.initials: S
authors.lastname: Giorgini
authors.forename: Canio
authors.initials: C
authors.lastname: Martinelli
authors.forename: Daniela
authors.initials: D
authors.lastname: Massi
authors.forename: Annalisa
authors.initials: A
authors.lastname: Lumini
authors.forename: Marco
authors.initials: M
authors.lastname: Mannucci
authors.forename: Leonetto
authors.initials: L
authors.lastname: Giglioli
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002114:Calcinosis / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007049:Iatrogenic Disease; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008297:Male; D017762:Nadroparin / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology*; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D017762:Nadroparin